Nordic Nanovector ASA: Financial Calendar for 2022
Oslo, Norway, 23 December 2021 Nordic Nanovector ASA (OSE: NANOV), a clinical-stage biotech company focused on CD37-targeted therapies for haematological cancers and immune diseases, announces its Financial Calendar for 2022. Q4 and FY 2021 Results: Thursday 17 FebruaryPublication of Annual Report 2021: Wednesday 6 AprilAnnual General Meeting: Thursday 28 AprilQ1 2022 Results: Friday 13 MayQ2 2022 Results: Wednesday 20 JulyQ3 2022 Results: Thursday 10 November The dates are subject to change.